Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2020
2020 World Conference on Lung Cancer
Conference Program for the 2020 World Conference on Lung Cancer
Presentation Date(s):- January 28 - 31, 2021
- Total Presentations: 1597
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
FP12 - Tumor Biology and Systems Biology - Basic and Translational Science
- Type: Posters (Featured)
- Track: Tumor Biology and Systems Biology - Basic and Translational Science
- Presentations: 12
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
FP12.05 - Molecular Landscape of Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Chinese Advanced Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Xiaomin Niu
- Abstract
Loading... -
+
FP12.13 - Therapeutic Index Predicts Clinical Outcome of both Treated and Treatment-Naïve NSCLC Patients Receiving Targeted- and Immune-Therapy
00:00 - 00:00 | Presenter: Xiaomin Niu
- Abstract
Loading...
-
+
FP14 - Targeted Therapy - Clinically Focused
- Type: Posters (Featured)
- Track: Targeted Therapy - Clinically Focused
- Presentations: 16
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
FP14.11 - Icotinib versus Chemotherapy as Adjuvant Treatment for Stage II–IIIA EGFR-Mutant NSCLC (EVIDENCE): A Randomized, Open-Label, Phase 3 Study
00:00 - 00:00 | Presenter: Caicun Zhou
- Abstract
Loading...
-
+
P76 - Targeted Therapy - Clinically Focused - EGFR
- Type: Posters
- Track: Targeted Therapy - Clinically Focused
- Presentations: 98
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P76.24 - A Randomized Phase 2 Trial of Anlotinib Plus Docetaxel vs Docetaxel as 2nd-Line Therapy for EGFR-Negative NSCLC (ALTER-L018)
00:00 - 00:00 | Presenter: Lin Wu
- Abstract
Loading... -
+
P76.48 - A CT-Based Radiomic Feature Predicts EGFR Mutation and Response to Targeted Therapy in NSCLC
00:00 - 00:00 | Presenter: Lin Wu
- Abstract
Loading... -
+
P76.63 - Dacomitinib Induces a Drastic Response in Metastatic Brain Lesions of Patients with EGFR-mutant Non-small-cell Lung Cancer: A Brief Report
00:00 - 00:00 | Presenter: Lin Wu
- Abstract
Loading... -
+
P76.65 - CNS Efficacy of AST2818 in Patients with T790M-Positive Advanced NSCLC: Data from a Phase I-II Dose-Expansion Study
00:00 - 00:00 | Presenter: Yuankai Shi
- Abstract
Loading...
-
+
P79 - Immunotherapy (Phase II/III Trials) - Immunotherapy Plus Chemotherapy
- Type: Posters
- Track: Immunotherapy (Phase II/III Trials)
- Presentations: 9
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P79.08 - Sintilimab ± IBI305 Plus Chemotherapy for Patients With EGFR-Mutant Non-Squamous NSCLC Failed to EGFR-TKI Treatment
00:00 - 00:00 | Presenter: Shun Lu
- Abstract
Loading...
-
+
P86 - Targeted Therapy - Clinically Focused - New Target
- Type: Posters
- Track: Targeted Therapy - Clinically Focused
- Presentations: 23
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P86.14 - Next-Generation Sequencing Guided the Gene Mutations Associated with mTOR-Inhibitors in Chinese Lung Cancer Patients
00:00 - 00:00 | Presenter: Lin Wu
- Abstract
Loading...
-
+
JICC01 - Joint IASLC-CAALC-CSCO Session: The Truth and Myth of Oral Anti-VEGFR Inhibitors for Advance NSCLC
- Type: Workshop
- Track: N.A.
- Presentations: 17
- Coordinates: 1/28/2021, 07:00 - 09:00, Scientific Program Auditorium
-
+
JICC01.11 - Icotinib versus Chemotherapy as Adjuvant Treatment for Stage II–IIIA EGFR-Mutant NSCLC (EVIDENCE): A Randomized, Open-Label, Phase 3 Study
08:25 - 08:30 | Presenter: Caicun Zhou
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
JICC01.12 - Molecular Landscape of Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Chinese Advanced Non-Small Cell Lung Cancer
08:30 - 08:35 | Presenter: Xiaomin Niu
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
